Tag: clinical trials
Analysis finds clinical trials frequently overlook people with disabilities
Disabilities were underreported in clinical trial data and commonly used as a basis for exclusion from trial participation in an analysis of 80 recent...
Q-FFICIENCY trial shows promise for temperature-controlled ablation
Use of temperature-controlled ablation for the treatment of atrial fibrillation (AF) is effective and highly efficient, according to Jose Osorio—the director of electrophysiology at...
FDA issues two final guidances for including patient perspectives in medical...
The US Food and Drug Administration (FDA) has issued two final guidances providing recommendations for including patient perspectives in medical device clinical studies.
As...
Trial underway to evaluate “modular” cardiac rhythm management system
Boston Scientific has announced the start of the MODULAR ATP clinical trial to evaluate the safety, performance and effectiveness of the mCRM modular therapy...
Adapt clinical studies to alleviate effect of pandemic
A viewpoint in the Journal of the American Medical Association (JAMA) has offered potential solutions to modifying ongoing randomised clinical trials during the COVID-19...
Late-breaking trial highlights positive safety and efficacy data for the LUMINIZE...
Boston Scientific announced data from the AF-FICIENT I study during a late-breaking clinical trial session at the 2019 European Heart Rhythm Association annual congress...
Clinical trial rules should protect patients and results not operational details,...
Rules governing the conduct of clinical trials are failing to produce the intended benefits for patients and should be rewritten through a transparent process...
Medtronic EffectivCRT-during atrial fibrillation algorithm can improve therapy delivery
The Cardiac Resynchronization Therapy Efficacy Enhancement (CRTee) study has shown that the Medtronic EffectivCRT-during atrial fibrillation algorithm can improve therapy delivery in heart failure...
Fewer cardiovascular drugs being studied in clinical trials
The number of cardiovascular drugs in the research pipeline has declined across all phases of development in the last 20 years—even as cardiovascular disease...